First Affiliated Hospital of Zhejiang University clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 4 with minor changes only.

1. Notable

   Transperineal Irreversible Electroporation for Benign Prostatic…Transperineal Irreversible Electroporation for Benign Prostatic Hyperplasia

   Primary and study completion pushed from May 29, 2026 to May 29, 2027

   Also in this update: Enrollment increased: 10 → 99 participants; Trial sites expanded: 1 → 10 locations

   First Affiliated Hospital of Zhejiang University·Not applicable· NCT06867315· Registry history of NCT06867315 on ClinicalTrials.gov (opens the registry)

   Updated Oct 14, 2026

2. Notable

   MESH · Microbiome and Enteric Signatures in Sepsis-associated…MESH · Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury

   Primary completion pushed from Feb 14, 2028 to Feb 14, 2030

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 200 → 1000 participants

   First Affiliated Hospital of Zhejiang University·Not specified· NCT07735182· Registry history of NCT07735182 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.